Loading…
Sunday, June 24 • 1:00pm - 4:30pm
#30: Implementing a Risk-Based Monitoring Solution: Understanding the Basics of a Sustainable Model

Sign up or log in to save this to your schedule and see who's attending!

Component Type: Tutorial
CE: CME 3.25; IACET 3.25; RN 3.25

The current clinical trial climate demands that sponsors find ways to reduce clinical trial complexity, drug development costs, and get more value from R&D budgets. Risk-based monitoring (RBM) allows organizations to target site monitoring activities for which risks can be best managed and deliver the greatest benefit to the study, and to become more effective and efficient in using resources, while increasing quality and patient safety. Participating TransCelerate Member Companies came together in 2012 to establish a model approach to high-quality RBM. To date, this effort has published a position paper on risk based monitoring, as well as several articles focused on sharing advancements, best practices and lessons learned from member companies adoption experience, all of which are publicly available. This short course, will define core concepts and main principles of the methodology, share key tools and discuss their use, share experiences and lessons learned, and address important questions about RBM and its implementation. An additional registration fee is required for all preconference short courses. Back to DIA 2018 Short Courses  

Who should attend?

This short course is designed for professionals involved with clinical and data operations.

Learning Objectives

At the conclusion of this short course, participants should be able to:
  • Define core concepts and main principles of the TransCelerate risk-based monitoring (RBM) methodology
  • Discuss the use of key tools in the RBM process
  • Identify common challenges with effective monitoring and discuss how they can be addressed through appropriate use of the RBM methodology



Speakers
avatar for Mary Arnould

Mary Arnould

Director, Clinical Science Operations, Astellas Pharma Global Development, Inc.
Mary has been in the pharmaceutical industry for over 20 years. She began her career as a site monitor and monitored studies in numerous therapuetic areas. Mary managed site monitors for over 10 years. She has been supporting the implementation of Risk Based Monitoring at Bristol... Read More →
EH

Esther Huffman

Associate Director, Monitoring Excellence, Bristol-Myers Squibb
Esther is an Associate Director in the Monitoring Excellence Group at Bristol-Myers Squibb, where she has spent the past several years developing and operationalizing the Risk-Based Monitoring methodology. In her current role, Esther facilitates the changes in technology, process... Read More →


Sunday June 24, 2018 1:00pm - 4:30pm
Room 160A Boston Convention and Exhibition Center 415 Summer Street, Boston, MA 02210 USA
  • format json
  • Credit Type CME, IACET, RN
  • Tags Tutorial